These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 4812958

  • 1. The chemotherapy of intracerebral vs subcutaneous murine gliomas. A comparative study of the effect of VM 26.
    Shapiro WR.
    Arch Neurol; 1974 Mar; 30(3):222-6. PubMed ID: 4812958
    [No Abstract] [Full Text] [Related]

  • 2. Corticosteroid hormones. Effects in an experimental brain tumor.
    Shapiro WR, Posner JB.
    Arch Neurol; 1974 Mar; 30(3):217-21. PubMed ID: 4812957
    [No Abstract] [Full Text] [Related]

  • 3. The development of an intracerebral glioma model for brain tumor chemotherapy.
    Wassenaar W, Tator CH, So WS.
    J Neurosurg; 1973 Sep; 39(3):293-301. PubMed ID: 4582100
    [No Abstract] [Full Text] [Related]

  • 4. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
    Shapiro WR.
    Cancer Res; 1972 Oct; 32(10):2178-85. PubMed ID: 5080762
    [No Abstract] [Full Text] [Related]

  • 5. Effect of trans-1,4-bis-2-dichlorbenzyl-aminoethyl-cyclohexane (AY-9944) on the experimental brain tumor G26A.
    Sirtori CR, Rodriguez GA, Guarino MJ, Azarnoff RS, Boulos BM.
    Arzneimittelforschung; 1972 May; 22(5):914-6. PubMed ID: 4626014
    [No Abstract] [Full Text] [Related]

  • 6. The action of corticosteroid hormones in an experimental brain tumour model.
    Shapiro WR.
    Afr J Med Sci; 1973 Oct; 4(4):351-8. PubMed ID: 4792050
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR.
    J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs.
    Geran RI, Congleton GF, Dudeck LE, Abbott BJ, Gargus JL.
    Cancer Chemother Rep 2; 1974 Dec; 4(4):53-87. PubMed ID: 4447935
    [No Abstract] [Full Text] [Related]

  • 17. [Incorporation of tritiated thymidine into human brain tumor cells].
    Arkhangel'skiĭ VV, Kotel'nikov VM, Kondakova LI.
    Vopr Neirokhir; 1971 Dec; 35(1):15-21. PubMed ID: 5562496
    [No Abstract] [Full Text] [Related]

  • 18. Intraneoplastic injection of CCNU for experimental brain tumor chemotherapy.
    Tator CH.
    Surg Neurol; 1977 Feb; 7(2):73-7. PubMed ID: 835077
    [Abstract] [Full Text] [Related]

  • 19. Dianhydrogalactitol (NSC-132313): pharmacokinetics in normal and tumor-bearing rat brain and antitumor activity against three intracerebral rodent tumors.
    Levin VA, Freeman-Dove MA, Maroten CE.
    J Natl Cancer Inst; 1976 Mar; 56(3):535-9. PubMed ID: 1255783
    [Abstract] [Full Text] [Related]

  • 20. Glucose analogues as potential agents for brain tumour diagnosis and treatment.
    Wassenaar W, Tator CH.
    Trans Am Neurol Assoc; 1973 Mar; 98():43-8. PubMed ID: 4784973
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.